Bank of America’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-201
| Closed | -$619 | – | 6404 |
|
|
2025
Q4 | $619 | Buy |
201
+183
| +1,017% | +$911 | ﹤0.01% | 6531 |
|
|
2025
Q3 | $117 | Sell |
18
-28,524
| -100% | -$209K | ﹤0.01% | 7824 |
|
|
2025
Q2 | $256K | Buy |
28,542
+28,115
| +6,584% | +$233K | ﹤0.01% | 6067 |
|
|
2025
Q1 | $2.69K | Sell |
427
-626
| -59% | -$5.86K | ﹤0.01% | 7294 |
|
|
2024
Q4 | $10.8K | Buy |
1,053
+68
| +7% | +$748 | ﹤0.01% | 6963 |
|
|
2024
Q3 | $12.7K | Sell |
985
-744
| -43% | -$10.9K | ﹤0.01% | 6846 |
|
|
2024
Q2 | $23.9K | Sell |
1,729
-1,463
| -46% | -$165K | ﹤0.01% | 6696 |
|
|
2024
Q1 | $993K | Buy |
3,192
+298
| +10% | +$79.4K | ﹤0.01% | 4942 |
|
|
2023
Q4 | $758K | Buy |
2,894
+375
| +15% | +$67.9K | ﹤0.01% | 5194 |
|
|
2023
Q3 | $492K | Buy |
2,519
+263
| +12% | +$47K | ﹤0.01% | 5323 |
|
|
2023
Q2 | $464K | Buy |
2,256
+161
| +8% | +$22.4K | ﹤0.01% | 5333 |
|
|
2023
Q1 | $211K | Buy |
2,095
+60
| +3% | +$7.43K | ﹤0.01% | 5902 |
|
|
2022
Q4 | $320K | Buy |
2,035
+142
| +8% | +$28.1K | ﹤0.01% | 5661 |
|
|
2022
Q3 | $474K | Sell |
1,893
-57
| -3% | -$16.9K | ﹤0.01% | 5447 |
|
|
2022
Q2 | $551K | Buy |
1,950
+306
| +19% | +$83.3K | ﹤0.01% | 5374 |
|
|
2022
Q1 | $330K | Sell |
1,644
-33
| -2% | -$7.25K | ﹤0.01% | 6113 |
|
|
2021
Q4 | $366K | Sell |
1,677
-533
| -24% | -$171K | ﹤0.01% | 6118 |
|
|
2021
Q3 | $1.01M | Buy |
2,210
+1,590
| +256% | +$601K | ﹤0.01% | 5062 |
|
|
2021
Q2 | $249K | Sell |
620
-27
| -4% | -$12.3K | ﹤0.01% | 5946 |
|
|
2021
Q1 | $374K | Buy |
647
+214
| +49% | +$134K | ﹤0.01% | 5600 |
|
|
2020
Q4 | $246K | Buy |
433
+55
| +15% | +$31K | ﹤0.01% | 5474 |
|
|
2020
Q3 | $212K | Sell |
378
-1,842
| -83% | -$1.15M | ﹤0.01% | 5265 |
|
|
2020
Q2 | $1.26M | Buy |
+2,220
| New | +$1.62M | ﹤0.01% | 3963 |
|
Other funds holding LYRA
Bank of America's LYRA Position: Q1 2026 in Review
Bank of America sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 201 shares — an estimated $619 sold.
Bank of America first reported a position in LYRA in Q2 2020 and held it in 23 quarters. The position peaked at $1.26M in Q2 2020. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- Bank of America reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 201 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $619.
- Bank of America first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 23 quarters.
- Bank of America's LYRA THERAPEUTICS INC position peaked at $1.26M in Q2 2020.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.